Skip to content

Anavex Life Sciences Corp.

AVXL· NasdaqCore metricsCIK 1314052

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -6.37%
Market cap
$91.13M
92.7M shares
Filings
638
—
—
—
$7.82M
Q3 2026N/M FY25 yoy
$6.74M
Q3 2026N/M FY25 yoy
-$2.66M
FY 2014derived
—
$0.08
Q3 2026N/M FY25 yoy
$118.33M
Q3 2026−22.4% FY25 yoy
$91.13M
—
—
0.8×
—
—

FY2025 figures · derived

Price

$0.983185.65%$5.8669past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$4.68MFY 2025
$7.32M-$71.83K0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-09-30$4,678,000reported
FY 20242024-09-30$7,320,000reported
FY 20232023-09-30$6,519,000reported
FY 20222022-09-30$947,000reported
FY 20212021-09-30$26,000 revisedreported
FY 20202020-09-30$179,973reported
FY 20192019-09-30$207,280reported
FY 20182018-09-30$255,092reported
FY 20172017-09-30$88,098reported
FY 20162016-09-30$11,322reported
FY 20152015-09-30$71,825reported
FY 20142014-09-30$7,089reported

Biological products, except diagnostic substances

Anavex Life Sciences Corp. is the 110th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR